Post Profile






When Drug Reviewers Leave The FDA, They Often Work For Pharma

More than a quarter of the Food and Drug Administration employees who approved cancer and hematology drugs from 2001 through 2010 left the agency and now work or consult for pharmaceutical companies,...
read more

share
See more about: Drug Administration

Related Posts


New Study Finds FDA Approval Process For Cancer Drugs Faster Than The European Medicines Agency (EMA)

Health : Medical News Today

The US Food and Drug Administration (FDA) is often criticized as inefficient compared to its European counterpart, the European Medicines Agency (EMA), particularly in the field of oncology. However, a new study appearing in Health ...

Injectafer receives US FDA approval for the treatment of Iron Deficiency Anaemia

Health : Medical News Today

Injectafer® has received US Food and Drug Administration (FDA) approval for the treatment of Iron Deficiency Anaemia (IDA). Luitpold Pharmaceuticals, Inc., the US partner of Vifor Pharma, a company of the Galenica Group, will immedi...

FDA Approves Lazanda® - First Fentanyl Nasal Spray - For The Management Of Breakthrough Pain In Cancer Patients

Health : Medical News Today

Archimedes Pharma Ltd., and its subsidiary, Archimedes Pharma U.S. Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Lazanda® (fentanyl) nasal spray for the management of breakthrough pain in cancer patie...

A.P. Pharma Announces FDA Acceptance Of APF530 New Drug Application For Chemotherapy-Induced Nausea And Vomiting

Health : Medical News Today

A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for APF530 for the potential treatment of chemoth...

VGX Pharmaceuticals Receives FDA Approval Of IND For Novel DNA Vaccine For Cervical Cancer Therapy

Health : Medical News Today

VGX Pharmaceuticals, Inc. (VGX) announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its DNA vaccine for cervical cancer therapy, VGX-3100. The Company ...

Comments


Copyright © 2016 Regator, LLC